Artwork

Contenido proporcionado por Aspen UK. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Aspen UK o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Player FM : aplicación de podcast
¡Desconecta con la aplicación Player FM !

Big Pharma: lessons from the pandemic

45:08
 
Compartir
 

Manage episode 332459835 series 2886146
Contenido proporcionado por Aspen UK. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Aspen UK o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

The past two years have been monumental for Big Pharma, yet campaigners continue to highlight the moral ambiguity of profit-making from the discovery, development and marketing of life-saving drugs. Our panellists answer hard hitting questions, including: Has the industry changed for the better, and will these changes stick? Could the industry’s solutions-based model be applied elsewhere? How quickly could we solve the climate crisis or income inequality using this model of public-private partnership, streamlined approval processes, and industry agility?

Join Aspen UK CEO Penny Richards in conversation with Professor Iain Buchan, Associate Pro Vice Chancellor Chair for Innovation at the University of Liverpool, and Danny Sriskandarajah, CEO of Oxfam Great Britain as they discuss the impact of Big Pharma on changing economies and the non-western world, and answer tough questions on the morality of profit-driven healthcare in situations of crisis.

This episode was recorded as a live broadcast at The Good Business Festival on 24 March 2022.

Support the show

  continue reading

134 episodios

Artwork
iconCompartir
 
Manage episode 332459835 series 2886146
Contenido proporcionado por Aspen UK. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Aspen UK o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

The past two years have been monumental for Big Pharma, yet campaigners continue to highlight the moral ambiguity of profit-making from the discovery, development and marketing of life-saving drugs. Our panellists answer hard hitting questions, including: Has the industry changed for the better, and will these changes stick? Could the industry’s solutions-based model be applied elsewhere? How quickly could we solve the climate crisis or income inequality using this model of public-private partnership, streamlined approval processes, and industry agility?

Join Aspen UK CEO Penny Richards in conversation with Professor Iain Buchan, Associate Pro Vice Chancellor Chair for Innovation at the University of Liverpool, and Danny Sriskandarajah, CEO of Oxfam Great Britain as they discuss the impact of Big Pharma on changing economies and the non-western world, and answer tough questions on the morality of profit-driven healthcare in situations of crisis.

This episode was recorded as a live broadcast at The Good Business Festival on 24 March 2022.

Support the show

  continue reading

134 episodios

ทุกตอน

×
 
Loading …

Bienvenido a Player FM!

Player FM está escaneando la web en busca de podcasts de alta calidad para que los disfrutes en este momento. Es la mejor aplicación de podcast y funciona en Android, iPhone y la web. Regístrate para sincronizar suscripciones a través de dispositivos.

 

Guia de referencia rapida